Literature DB >> 22820675

N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.

Irena Smaga1, Bartosz Pomierny, Weronika Krzyżanowska, Lucyna Pomierny-Chamioło, Joanna Miszkiel, Ewa Niedzielska, Agata Ogórka, Małgorzata Filip.   

Abstract

The growing body of evidence implicates the significance of oxidative stress in the pathophysiology of depression. The aim of this paper was to examine N-acetylcysteine (NAC) - a putative precursor of the most important tissue antioxidant glutathione - in an animal model of depression and in ex vivo assays to detect oxidative stress parameters. Imipramine (IMI), a classical and clinically-approved antidepressant drug was also under investigation. Male Wistar rats which underwent either bulbectomy (BULB; removal of the olfactory bulbs) or sham surgery (SHAM; olfactory bulbs were left undestroyed) were treated acutely or repeatedly with NAC (50-100mg/kg, ip) or IMI (10mg/kg, ip). Following 10-daily injections with NAC or IMI or their solvents, or 9-daily injections with a corresponding solvent plus acute NAC or acute IMI forced swimming test on day 10, and locomotor activity were performed; immediately after behavioral tests animals were decapitated. Biochemical tests (the total antioxidant capacity - TAC and the superoxide dismutase activity - SOD) were performed on homogenates in several brain structures. In behavioral studies, chronic (but not acute) administration of NAC resulted in a dose-dependent reduction in the immobility time seen only in BULB rats while chronic IMI produced a significant decrease in this parameter in both SHAM and BULB animals. On the other hand, chronic administration of NAC and IMI resulted in a significant increase in cellular antioxidant mechanisms (SOD activity) that reversed the effects of BULB in the frontal cortex, hippocampus and striatum. Our study further supports the antidepressant-like activity of NAC and links its effect as well as IMI actions with the enhancement of brain SOD activity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820675     DOI: 10.1016/j.pnpbp.2012.06.018

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  25 in total

1.  Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Authors:  Negin Nouraei; Lauren Zarger; Justin N Weilnau; Jimin Han; Daniel M Mason; Rehana K Leak
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-12       Impact factor: 4.219

2.  N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.

Authors:  Marisa Möller; Jan L Du Preez; Francois P Viljoen; Michael Berk; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2013-09-03       Impact factor: 3.584

3.  N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy.

Authors:  Martina Tallarico; Antonio Leo; Lorenza Guarnieri; Maria Caterina Zito; Carmen De Caro; Ferdinando Nicoletti; Emilio Russo; Andrew Constanti; Giovambattista De Sarro; Rita Citraro
Journal:  Mol Neurobiol       Date:  2022-02-15       Impact factor: 5.590

4.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

5.  N-acetylcysteine amide (AD4) reduces cocaine-induced reinstatement.

Authors:  Joanna Jastrzębska; Malgorzata Frankowska; Malgorzata Filip; Daphne Atlas
Journal:  Psychopharmacology (Berl)       Date:  2016-07-28       Impact factor: 4.530

Review 6.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

7.  Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects.

Authors:  Marwa M Al-Samhari; Nouf M Al-Rasheed; Salim Al-Rejaie; Nawal M Al-Rasheed; Iman H Hasan; Ayman M Mahmoud; Nduna Dzimiri
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-06

8.  A pilot study of cortical glutathione in youth with depression.

Authors:  Rachel D Freed; Cecilia N Hollenhorst; Nora Weiduschat; Xiangling Mao; Guoxin Kang; Dikoma C Shungu; Vilma Gabbay
Journal:  Psychiatry Res Neuroimaging       Date:  2017-10-02       Impact factor: 2.376

9.  Behavioral assessment of acute inhibition of system xc (-) in rats.

Authors:  Victoria Lutgen; Jon Resch; Krista Qualmann; Nicholas J Raddatz; Cristina Panhans; Ellen M Olander; Linghai Kong; SuJean Choi; John R Mantsch; David A Baker
Journal:  Psychopharmacology (Berl)       Date:  2014-05-15       Impact factor: 4.530

10.  Mood disorders and complementary and alternative medicine: a literature review.

Authors:  Naseem Akhtar Qureshi; Abdullah Mohammed Al-Bedah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-14       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.